BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carrera AN, Grant MKO, Zordoky BN. CYP1B1 as a therapeutic target in cardio-oncology. Clin Sci (Lond) 2020;134:2897-927. [PMID: 33185690 DOI: 10.1042/CS20200310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hollis PR, Mobley RJ, Bhuju J, Abell AN, Sutter CH, Sutter TR. CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells. IJMS 2022;23:9670. [DOI: 10.3390/ijms23179670] [Reference Citation Analysis]
2 Huwait E, Ayoub M, Karim S. Investigation of the Molecular Mechanisms Underlying the Antiatherogenic Actions of Kaempferol in Human THP-1 Macrophages. Int J Mol Sci 2022;23:7461. [PMID: 35806463 DOI: 10.3390/ijms23137461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lang NN, Touyz RM. Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity. Clin Sci (Lond) 2021;135:2661-3. [PMID: 34881389 DOI: 10.1042/CS20210986] [Reference Citation Analysis]
4 Lu Y, Nanayakkara G, Sun Y, Liu L, Xu K, Drummer C 4th, Shao Y, Saaoud F, Choi ET, Jiang X, Wang H, Yang X. Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammation. Redox Biol 2021;47:102142. [PMID: 34598017 DOI: 10.1016/j.redox.2021.102142] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Jiang W, Xia T, Liu C, Li J, Zhang W, Sun C. Remodeling the Epigenetic Landscape of Cancer-Application Potential of Flavonoids in the Prevention and Treatment of Cancer. Front Oncol 2021;11:705903. [PMID: 34235089 DOI: 10.3389/fonc.2021.705903] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Mikstacka R, Dutkiewicz Z. New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies. Processes 2021;9:817. [DOI: 10.3390/pr9050817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]